Portola Pharmaceuticals, Inc. EPS - Earnings per Share 2013-2020 | PTLA
Portola Pharmaceuticals, Inc. eps - earnings per share from 2013 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Portola Pharmaceuticals, Inc. Annual EPS |
| 2019 |
$-4.06 |
| 2018 |
$-5.31 |
| 2017 |
$-4.81 |
| 2016 |
$-4.76 |
| 2015 |
$-4.36 |
| 2014 |
$-3.19 |
| 2013 |
$-3.65 |
| 2012 |
$5.55 |
| 2011 |
$0.06 |
| 2010 |
$-16.79 |
| Portola Pharmaceuticals, Inc. Quarterly EPS |
| 2020-03-31 |
$-0.88 |
| 2019-12-31 |
$-1.24 |
| 2019-09-30 |
$-0.68 |
| 2019-06-30 |
$-0.97 |
| 2019-03-31 |
$-1.17 |
| 2018-12-31 |
$-1.34 |
| 2018-09-30 |
$-1.08 |
| 2018-06-30 |
$-1.61 |
| 2018-03-31 |
$-1.28 |
| 2017-12-31 |
$-1.44 |
| 2017-09-30 |
$-1.41 |
| 2017-06-30 |
$-1.22 |
| 2017-03-31 |
$-0.74 |
| 2016-12-31 |
$-0.95 |
| 2016-09-30 |
$-1.64 |
| 2016-06-30 |
$-1.02 |
| 2016-03-31 |
$-1.15 |
| 2015-12-31 |
$-1.24 |
| 2015-09-30 |
$-1.05 |
| 2015-06-30 |
$-1.12 |
| 2015-03-31 |
$-0.95 |
| 2014-12-31 |
$-0.82 |
| 2014-09-30 |
$-0.86 |
| 2014-06-30 |
$-0.76 |
| 2014-03-31 |
$-0.75 |
| 2013-12-31 |
$11.29 |
| 2013-09-30 |
$-0.53 |
| 2013-06-30 |
$-1.47 |
| 2013-03-31 |
$-12.94 |
| 2012-09-30 |
$-8.38 |
| 2012-06-30 |
$1.67 |
